PACS Group (PACS) Stock Price, News & Analysis

Company Overview

PACS Group, Inc. is a U.S. healthcare services company that operates skilled nursing and post-acute care facilities. Its facilities provide short-term rehabilitation, long-term skilled nursing, nursing care, and related clinical services for patients recovering from illness, injury, surgery, or hospitalization.

The company’s broader care offerings may include assisted living, memory care, behavioral health, and other specialized post-acute services, depending on the facility and market. PACS Group focuses on operating and supporting healthcare centers through clinical, administrative, and technology resources intended to improve care coordination and facility performance.

Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across the United States, with a concentration in Western markets. The company became publicly traded on the New York Stock Exchange in 2024. Its leadership includes Jason Murray, who has served as chief executive officer and has been involved in the company’s development and expansion.

Key Stats

• Today's Range: $40.78 to $41.93
• 50-Day Range: $41.65 to $48.61
• 52-Week Range: $10.31 to $49.49
• Volume: 531,165 shs
• Average Volume: 903,446 shs
• Market Capitalization: $6.51 billion
• P/E Ratio: 23.91
• Dividend Yield: N/A
• Price Target: $58.80
• Consensus Rating: Moderate Buy

PACS Group Stock Analysis - MarketRank™

PACS Group scored higher than 95% of companies evaluated by MarketBeat, and ranked 20th out of 897 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

PACS Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on no strong buy ratings, 5 buy ratings, 2 hold ratings, and no sell ratings.

Upside Potential

PACS Group has a consensus price target of $58.80, representing about 43.0% upside from its current price of $41.12.

Amount of Analyst Coverage

PACS Group has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 3.1 / 5
• Proj. Earnings Growth: 20.66%

Earnings Growth

Earnings for PACS Group are expected to grow by 20.66% in the coming year, from $2.13 to $2.57 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of PACS Group is 23.89, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.02.

Price to Earnings Ratio vs. Sector

The P/E ratio of PACS Group is 23.89, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 274.74.

Price to Earnings Growth Ratio

PACS Group has a PEG Ratio of 1.31. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

PACS Group has a P/B Ratio of 6.76. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

7.03% of the float of PACS Group has been sold short.

Short Interest Ratio / Days to Cover

PACS Group has a short interest ratio ("days to cover") of 5.38.

Change versus previous month

Short interest in PACS Group has recently decreased by 7.11%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

PACS Group does not currently pay a dividend.

Dividend Growth

PACS Group does not have a long track record of dividend growth.

News and Social Media

• Score: 3.5 / 5
• News Sentiment: 0.61

News Sentiment

PACS Group has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.50 average news sentiment score of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 9 news articles for PACS Group this week, compared to 4 articles on an average week.

Search Interest

Only 4 people have searched for PACS on MarketBeat in the last 30 days. This is a decrease of -73% compared to the previous 30 days.

MarketBeat Follows

9 people have added PACS Group to their MarketBeat watchlist in the last 30 days. This is an increase of 50% compared to the previous 30 days.

Company Ownership

• Score: 1.4 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, PACS Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $57,456,006.00 in company stock.

Percentage Held by Insiders

70.10% of the stock of PACS Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

PACS Group has minimal institutional ownership at this time.

Company Calendar

• Last Earnings: 8/04/2026
• Today: 9/23/2026
• Next Earnings (Estimated): 11/09/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Facilities
• Current Symbol: NYSE:PACS
• Previous Symbol: NYSE:PACS
• CIK: 2001184
• Web: pacs.com
• Phone: 801-447-9829
• Fax: N/A
• Employees: 47,455
• Year Founded: N/A

Price Target and Rating

• Average Price Target for PACS Group: $58.80
• High Price Target: $62.00
• Low Price Target: $57.00
• Potential Upside/Downside: +43.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.71
• Research Coverage: 7 Analysts

Profitability

• EPS (Trailing Twelve Months): $1.72
• Trailing P/E Ratio: 23.91
• Forward P/E Ratio: 19.31
• P/E Growth: 1.31
• Net Income: $191.54 million
• Net Margins: 4.85%
• Pretax Margin: 6.89%
• Return on Equity: 29.55%
• Return on Assets: 5.23%

Debt

• Debt-to-Equity Ratio: 0.21
• Current Ratio: 0.91
• Quick Ratio: 0.91

Sales & Book Value

• Annual Sales: $5.29 billion
• Price / Sales: 1.23
• Cash Flow: $1.56 per share
• Price / Cash Flow: 26.31
• Book Value: $6.08 per share
• Price / Book: 6.76

Miscellaneous

• Outstanding Shares: 158,270,000
• Free Float: 47,323,000
• Market Cap: $6.51 billion
• Optionable: Optionable
• Beta: -0.13